Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Pain Modulation by Intravenous Esketamine in Complex Regional Pain Syndrome: a Non-inferiority Study

NCT05212571 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05212571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05212571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Pain Modulation by Intravenous Esketamine in Complex Regional Pain Syndrome: a Non-inferiority Study
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 19, 2022
Completion date
October 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

complex regional pain syndromes, crps (complex regional pain syndromes)